Form 8-K - Current report:
SEC Accession No. 0001839882-24-020329
Filing Date
2024-07-01
Accepted
2024-07-01 06:45:30
Documents
13
Period of Report
2024-06-28
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_062824.htm   iXBRL 8-K 24354
  Complete submission text file 0001839882-24-020329.txt   196338

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE tnxp-20240628.xsd EX-101.SCH 3024
3 XBRL LABEL FILE tnxp-20240628_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE tnxp-20240628_pre.xml EX-101.PRE 22365
15 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-8k_062824_htm.xml XML 3543
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 241088118
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)